NRx Pharmaceuticals, Inc. (NRXP)

NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $56.54 million. The enterprise value is $59.38 million.

Market Cap	56.54M
Enterprise Value	59.38M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

NRXP has 17.29 million shares outstanding. The number of shares has increased by 54.22% in one year.

Current Share Class	17.29M
Shares Outstanding	17.29M
Shares Change (YoY)	+54.22%
Shares Change (QoQ)	+33.95%
Owned by Insiders (%)	10.31%
Owned by Institutions (%)	6.27%
Float	13.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	25.15
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.22

Current Ratio	0.22
Quick Ratio	0.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-191.74%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	69.37%
Revenue Per Employee	n/a
Profits Per Employee	-$12.06M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.15% in the last 52 weeks. The beta is 1.55, so NRXP's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-8.15%
50-Day Moving Average	2.22
200-Day Moving Average	2.05
Relative Strength Index (RSI)	79.36
Average Volume (20 Days)	407,708

Short Selling Information

The latest short interest is 1.11 million, so 6.43% of the outstanding shares have been sold short.

Short Interest	1.11M
Short Previous Month	1.21M
Short % of Shares Out	6.43%
Short % of Float	8.32%
Short Ratio (days to cover)	5.25

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.45M
Pretax Income	-25.64M
Net Income	-24.11M
EBITDA	-17.45M
EBIT	-17.45M
Earnings Per Share (EPS)	-$1.92

Balance Sheet

The company has $5.55 million in cash and $8.40 million in debt, giving a net cash position of -$2.85 million or -$0.16 per share.

Cash & Cash Equivalents	5.55M
Total Debt	8.40M
Net Cash	-2.85M
Net Cash Per Share	-$0.16
Equity (Book Value)	-25.16M
Book Value Per Share	-1.47
Working Capital	-25.50M

Cash Flow

Operating Cash Flow	-10.45M
Capital Expenditures	n/a
Free Cash Flow	-10.45M
FCF Per Share	-$0.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.22%
Shareholder Yield	-54.22%
Earnings Yield	-42.65%
FCF Yield	-18.48%

Analyst Forecast

The average price target for NRXP is $28.50, which is 771.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.50
Price Target Difference	771.56%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Apr 2, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2